Syneos Health Releases 2025 Health Trends
Future of Health to be Powered by Data & Technology – Generating Innovations Poised to Tackle Decades’ Long Industry Obstacles
December 20, 2024
MORRISVILLE, N.C., December 20, 2024 - Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today released its 2025 Health Trends Report: Reimagining What’s Possible.
The Report reveals how the fusion of data, technology, and empathy is reshaping healthcare, from rare disease research to genetic medicine, with the potential to revolutionize patient care and outcomes. Topics focus on reimagining how gaps in care can be narrowed, and models can be reshaped, to be more precise, personalized and holistic.
The 10 trends set to catalyze the year ahead include:
1. AI Alchemy: Reimagining Rare Disease Research
AI is poised to play an outsized role in rare disease drug development, diagnosis and treatment, at a time when unmet needs remain vast and time is precious for patients and families who are awaiting new therapies.
2. FemTech’s Breakthrough Moment
Recent developments in women’s health services and digital technology/therapeutics are validating that women’s health is not a niche market but a substantial and viable sector for investment, shaping new models of healthcare for all.
3. The Predictive Edge: Omnichannel’s Maturity Curve
Predictive sales intelligence tools, including AI advances and a deepening understanding of behavior and motivation, are altering HCP engagement, with greater customization to build enduring relationships.
4. Precision in Psychiatry: Are We There Yet?
Researchers and innovators are coalescing around new approaches that are more precise, tech-enabled, data-driven, efficient and accessible. Digital therapeutics are leading the way.
5. Redrawing the Map: How Data, AI and Engagement Are Deepening Our Understanding of Patient Experiences
Vast new sources of patient experience data are fusing with new approaches to patient engagement, deepening insights for personalized care and improved outcomes, especially for underrepresented patient communities.
6. Through a Different Lens: The Emerging Role for Medical Affairs in Clinical Trials
As clinical trials become increasingly complex and patient recruitment delays continue to be ever-present, a new Medical Affairs role is emerging focused on supporting clinical investigators and sites.
7. Mainstreaming Genetic Medicine
Beyond its groundbreaking impact for treating cancer and certain rare diseases, researchers are now investigating the potential genetic medicine may hold for treating more prevalent, chronic conditions.
8. Getting “Real” About RWE
Researchers will be digging deeper into more diverse and non-traditional data sources to develop the custom Real World Evidence (RWE) needed to answer specific research questions, requiring rigorous science and creative thinking to improve patient care.
9. Diversity in Clinical Trials: The Team Factor Comes into Focus
Workforce development initiatives, plus efforts to expand clinical research site local communities, are building the clinical trial teams of the future that are more representative of the patient communities they serve.
10. Opening New Frontiers for Clinical Research in Southeast Asia
Ongoing development in research infrastructure and regulatory reforms are starting to make previously underserved countries excellent options for global research, improving access to new therapies.
2025 Health Trends Implications – Connect with Us to Learn More
- Visit trends.health to read the 2025 Health Trends Report and related tools.
- Discuss implications for biopharma companies with Syneos Health Subject Matter Experts – register here to connect with us on our January 28th webinar.
- Bookmark the Syneos Health podcast page for further coverage of 2025 Health Trends.
Follow Syneos Health on LinkedIn where leaders share their perspectives.
About Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.
Press/Media Contact:
Meg Byers
Director, External Communications
+1 607 215 1330
